BCKDK and metabolic dysfunction-associated steatotic liver disease: Thus, our data support the notion that measurement of plasma BCKAs or the ratio of BCKA/BCAA, which provides correction for systemic BCAA load, provides a sensitive index of the balance of BCKDK/PPM1K in the liver and NAFLD status.